Ignite Creation Date:
2025-12-25 @ 3:13 AM
Ignite Modification Date:
2026-01-11 @ 4:49 PM
Study NCT ID:
NCT03373305
Status:
WITHDRAWN
Last Update Posted:
2019-04-30
First Post:
2017-11-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Brentuximab Vedotin and Lenalidomide in Treating Patients With Relapsed or Refractory T-Cell Lymphomas
Sponsor:
Organization: